Insider Trading › CVS › Insiders
CVS HEALTH Corp
CVS·NYSE·
United States·Insider activity
United States·Insider activity$86.43
-0.58 (-0.67%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
CVS
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
CVSS&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
In the last 180 days, CVS insiders filed 0 purchases ($0) and 8 sales ($323.7M) on the open market, by 2 insiders. Newest filing May 21, 2026 (4 months ago).
Net Insider Buying by Quarter
Shares bought (+) or sold (−) on the open market by CVS insiders · Form 4 · last two years
On Record
$0Purchases · 180 days
$323.7MSales · 180 days
406Open-market transactions on record
2Insiders filing · 180 days
Purchases (code P) and sales (code S) of CVS common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).
Insider Transactions
406 on record · newest trade first · the newest 300 shown
AllPurchasesSalesOfficers & directors
| Insider | Type | Shares | Price | Value | Held after | Traded | Filed | |
|---|---|---|---|---|---|---|---|---|
| ROBBINS LARRYDirector | Sale | −370.5K | $93.45 | $34.6M | 4.8Mindirect | May 21, 2026 | May 21, 2026 | Form 4 ↗ |
| ROBBINS LARRYDirector | Sale | −800 | $96.28 | $77K | 5.2Mindirect | May 20, 2026 | May 21, 2026 | Form 4 ↗ |
| ROBBINS LARRYDirector | Sale | −66.9K | $95.67 | $6.4M | 5.2Mindirect | May 20, 2026 | May 21, 2026 | Form 4 ↗ |
| ROBBINS LARRYDirector | Sale | −152.7K | $94.81 | $14.5M | 5.3Mindirect | May 20, 2026 | May 21, 2026 | Form 4 ↗ |
| ROBBINS LARRYDirector | Sale | −797.6K | $93.48 | $74.6M | 5.4Mindirect | May 20, 2026 | May 21, 2026 | Form 4 ↗ |
| ROBBINS LARRYDirector | Sale | −151 | $95.18 | $14K | 6.2Mindirect | May 19, 2026 | May 21, 2026 | Form 4 ↗ |
| ROBBINS LARRYDirector | Sale | −2.0M | $94.45 | $187.3M | 6.2Mindirect | May 19, 2026 | May 21, 2026 | Form 4 ↗ |
| Mandadi TilakEVP, Chief Exp & Tech Officer | Sale | −69.6K | $89.58 | $6.2M | 10.1Kdirect | May 8, 2026 | May 11, 2026 | Form 4 ↗ |
| Finucane Anne A.Director | Sale | −7,500 | $71.02 | $533K | 22.2Kindirect | Aug 20, 2025 | Aug 29, 2025 | Form 4 ↗ |
| SANSONE GUY PDirector | Purchase | +1,570 | $63.70 | $100K | 12.0Kdirect | Jun 5, 2025 | Jun 9, 2025 | Form 4 ↗ |
| ROBBINS LARRYDirector | Sale | −150.0K | $66.67 | $10.0M | 8.2Mindirect | May 6, 2025 | May 6, 2025 | Form 4 ↗ |
| ROBBINS LARRYDirector | Sale | −97.0K | $67.99 | $6.6M | 8.3Mindirect | May 5, 2025 | May 6, 2025 | Form 4 ↗ |
| ROBBINS LARRYDirector | Sale | −1.2M | $67.37 | $82.7M | 8.4Mindirect | May 5, 2025 | May 6, 2025 | Form 4 ↗ |
| ROBBINS LARRYDirector | Sale | −373.8K | $69.66 | $26.0M | 9.7Mindirect | May 2, 2025 | May 6, 2025 | Form 4 ↗ |
| ROBBINS LARRYDirector | Sale | −222.6K | $68.38 | $15.2M | 10.0Mindirect | May 2, 2025 | May 6, 2025 | Form 4 ↗ |
| ROBBINS LARRYDirector | Sale | −1.7M | $67.39 | $113.2M | 10.3Mindirect | May 2, 2025 | May 6, 2025 | Form 4 ↗ |
| Clark James DavidSVP, Cont & Chief Acct Officer | Sale | −7,513 | $66.35 | $498K | 8,394direct | Mar 5, 2025 | Mar 7, 2025 | Form 4 ↗ |
| Mahoney Michael FDirector | Purchase | +30.0K | $66.70 | $2.0M | 39.4Kdirect | Feb 18, 2025 | Feb 19, 2025 | Form 4 ↗ |
| Nelson Steven HEVP and President, Aetna | Purchase | +24 | $53.70 | $1K | 24indirect | Jan 23, 2025 | Jan 27, 2026 | Form 4 ↗ |
| CAPOZZI HEIDI BEVP and Chief People Officer | Purchase | +35 | $56.85 | $2K | 85indirect | Oct 23, 2024 | Oct 14, 2025 | Form 4 ↗ |
| CAPOZZI HEIDI BEVP and Chief People Officer | Purchase | +10 | $62.24 | $622 | 50indirect | Oct 2, 2024 | Oct 14, 2025 | Form 4 ↗ |
| CAPOZZI HEIDI BEVP and Chief People Officer | Purchase | +35 | $56.47 | $2K | 40indirect | Sep 9, 2024 | Oct 14, 2025 | Form 4 ↗ |
| LUDWIG EDWARD JDirector | Purchase | +1,000 | $53.88 | $54K | 21.6Kdirect | May 2, 2024 | May 2, 2024 | Form 4 ↗ |
| Mahoney Michael FDirector | Purchase | +9,181 | $54.49 | $500K | 9,356direct | May 2, 2024 | May 2, 2024 | Form 4 ↗ |
| Shah Prem SEVP and Pres-Pharm, Consumer W | Sale | −29.5K | $76.95 | $2.3M | 39.8Kdirect | Feb 16, 2024 | Feb 16, 2024 | Form 4 ↗ |
| LUDWIG EDWARD JDirector | Purchase | +2,000 | $70.47 | $141K | 20.6Kdirect | Nov 3, 2023 | Nov 6, 2023 | Form 4 ↗ |
| Clark James DavidSVP, Cont & Chief Acct Officer | Sale | −23.1K | $74.94 | $1.7M | 4,698direct | Aug 3, 2023 | Aug 4, 2023 | Form 4 ↗ |
| Clark James DavidSVP, Cont & Chief Acct Officer | Sale | −2,631 | $74.79 | $197K | 27.8Kdirect | Aug 3, 2023 | Aug 4, 2023 | Form 4 ↗ |
| Lynch Karen SPresident and CEO · Director | Purchase | +14.0K | $69.75 | $977K | 431.4Kdirect | May 3, 2023 | May 5, 2023 | Form 4 ↗ |
| Moriarty Thomas MEVP & General Counsel | Sale | −36.5K | $98.24 | $3.6M | 608.1Kdirect | Dec 15, 2022 | Dec 16, 2022 | Form 4 ↗ |
| Moriarty Thomas MEVP & General Counsel | Sale | −101.0K | $98.40 | $9.9M | 608.1Kdirect | Dec 15, 2022 | Dec 16, 2022 | Form 4 ↗ |
| Lotvin AlanEVP&President-PharmacyServices | Sale | −22.5K | $104.00 | $2.3M | 109.2Kdirect | Aug 4, 2022 | Aug 5, 2022 | Form 4 ↗ |
| Lotvin AlanEVP&President-PharmacyServices | Sale | −50.5K | $98.00 | $4.9M | 109.2Kdirect | Aug 3, 2022 | Aug 5, 2022 | Form 4 ↗ |
| Lotvin AlanEVP&President-PharmacyServices | Sale | −70.4K | $98.00 | $6.9M | 109.2Kdirect | Aug 3, 2022 | Aug 5, 2022 | Form 4 ↗ |
| Finke Daniel PEVP/Pres, Health Care Benefits | Sale | −9,546 | $100.00 | $955K | 32.1Kdirect | Aug 3, 2022 | Aug 5, 2022 | Form 4 ↗ |
| Moriarty Thomas MEVP & General Counsel | Sale | −38.9K | $95.00 | $3.7M | 626.3Kdirect | Jun 28, 2022 | Jun 30, 2022 | Form 4 ↗ |
| Moriarty Thomas MEVP & General Counsel | Sale | −50.5K | $95.00 | $4.8M | 626.3Kdirect | Jun 28, 2022 | Jun 30, 2022 | Form 4 ↗ |
| Moriarty Thomas MEVP & General Counsel | Sale | −49.3K | $95.00 | $4.7M | 626.3Kdirect | Jun 28, 2022 | Jun 30, 2022 | Form 4 ↗ |
| Shah Prem SEVP and Co-President of Retail | Sale | −3,130 | $105.00 | $329K | 43.5Kdirect | Apr 8, 2022 | Apr 12, 2022 | Form 4 ↗ |
| Shah Prem SEVP and Co-President of Retail | Sale | −4,103 | $105.00 | $431K | 46.6Kdirect | Apr 8, 2022 | Apr 12, 2022 | Form 4 ↗ |
| Shah Prem SEVP and Co-President of Retail | Sale | −5,719 | $105.00 | $600K | 46.6Kdirect | Apr 8, 2022 | Apr 12, 2022 | Form 4 ↗ |
| Shah Prem SEVP and Co-President of Retail | Sale | −3,157 | $105.00 | $331K | 46.6Kdirect | Apr 8, 2022 | Apr 12, 2022 | Form 4 ↗ |
| Shah Prem SEVP and Co-President of Retail | Sale | −845 | $105.00 | $89K | 46.6Kdirect | Apr 8, 2022 | Apr 12, 2022 | Form 4 ↗ |
| Finke Daniel PEVP/Pres, Health Care Benefits | Sale | −5,941 | $100.00 | $594K | 32.1Kdirect | Apr 5, 2022 | Apr 6, 2022 | Form 4 ↗ |
| Finke Daniel PEVP/Pres, Health Care Benefits | Sale | −12.0K | $100.13 | $1.2M | 38.1Kdirect | Apr 4, 2022 | Apr 6, 2022 | Form 4 ↗ |
| Finke Daniel PEVP/Pres, Health Care Benefits | Sale | −27.2K | $100.13 | $2.7M | 50.1Kdirect | Apr 4, 2022 | Apr 6, 2022 | Form 4 ↗ |
| Finke Daniel PEVP/Pres, Health Care Benefits | Sale | −16.2K | $100.13 | $1.6M | 50.1Kdirect | Apr 4, 2022 | Apr 6, 2022 | Form 4 ↗ |
| Shah Prem SEVP and Co-President of Retail | Sale | −5,346 | $104.70 | $560K | 59.1Kdirect | Mar 30, 2022 | Mar 31, 2022 | Form 4 ↗ |
| Shah Prem SEVP and Co-President of Retail | Sale | −2,935 | $106.65 | $313K | 59.1Kdirect | Mar 17, 2022 | Mar 18, 2022 | Form 4 ↗ |
| Shah Prem SEVP and Co-President of Retail | Sale | −1,689 | $106.65 | $180K | 59.1Kdirect | Mar 17, 2022 | Mar 18, 2022 | Form 4 ↗ |
| Moriarty Thomas MEVP & General Counsel | Sale | −51.4K | $105.00 | $5.4M | 836.8Kdirect | Mar 15, 2022 | Mar 17, 2022 | Form 4 ↗ |
| LUDWIG EDWARD JDirector | Purchase | +1,000 | $105.90 | $106K | 18.3Kdirect | Feb 10, 2022 | Feb 11, 2022 | Form 4 ↗ |
| Brennan Troyen AEVP and Chief Medical Officer | Sale | −47.9K | $110.00 | $5.3M | 138.2Kdirect | Feb 3, 2022 | Feb 4, 2022 | Form 4 ↗ |
| Lotvin AlanEVP&President-PharmacyServices | Sale | −21.4K | $106.50 | $2.3M | 61.3Kdirect | Feb 1, 2022 | Feb 2, 2022 | Form 4 ↗ |
| Clark James DavidSVP, Cont & Chief Acct Officer | Sale | −6,059 | $109.00 | $660K | 17.5Kdirect | Jan 28, 2022 | Feb 1, 2022 | Form 4 ↗ |
| Roberts Jonathan CEVP & Chief Operating Officer | Sale | −68.5K | $107.50 | $7.4M | 107.1Kdirect | Jan 27, 2022 | Jan 28, 2022 | Form 4 ↗ |
| Roberts Jonathan CEVP & Chief Operating Officer | Sale | −108.9K | $95.00 | $10.3M | 107.1Kdirect | Nov 3, 2021 | Nov 5, 2021 | Form 4 ↗ |
| Brennan Troyen AEVP and Chief Medical Officer | Sale | −28.2K | $90.00 | $2.5M | 138.2Kdirect | Nov 1, 2021 | Nov 3, 2021 | Form 4 ↗ |
| Brennan Troyen AEVP and Chief Medical Officer | Sale | −80.8K | $88.00 | $7.1M | 138.2Kdirect | Oct 26, 2021 | Oct 28, 2021 | Form 4 ↗ |
| Brennan Troyen AEVP and Chief Medical Officer | Sale | −1,955 | $88.00 | $172K | 219.0Kdirect | Oct 26, 2021 | Oct 28, 2021 | Form 4 ↗ |
| Brennan Troyen AEVP and Chief Medical Officer | Sale | −2,625 | $87.00 | $228K | 140.2Kdirect | Sep 2, 2021 | Sep 7, 2021 | Form 4 ↗ |
| LUDWIG EDWARD JDirector | Purchase | +3,000 | $79.55 | $239K | 17.3Kdirect | Aug 5, 2021 | Aug 5, 2021 | Form 4 ↗ |
| Lotvin AlanEVP&President-PharmacyServices | Sale | −2,781 | $83.67 | $233K | 61.0Kdirect | Jun 28, 2021 | Jun 29, 2021 | Form 4 ↗ |
| Brennan Troyen AEVP and Chief Medical Officer | Sale | −67.6K | $86.00 | $5.8M | 142.8Kdirect | Jun 15, 2021 | Jun 17, 2021 | Form 4 ↗ |
| Finke Daniel PEVP/Pres, Health Care Benefits | Sale | −37.6K | $86.60 | $3.3M | 23.3Kdirect | Jun 7, 2021 | Jun 8, 2021 | Form 4 ↗ |
| Moriarty Thomas MEVP & General Counsel | Sale | −109.5K | $86.00 | $9.4M | 0direct | May 10, 2021 | May 12, 2021 | Form 4 ↗ |
| Brennan Troyen AEVP and Chief Medical Officer | Sale | −9,477 | $84.00 | $796K | 144.7Kdirect | May 7, 2021 | May 10, 2021 | Form 4 ↗ |
| Boratto Eva CEVP & CFO | Sale | −4,905 | $80.00 | $392K | 115.3Kdirect | May 4, 2021 | May 6, 2021 | Form 4 ↗ |
| Moriarty Thomas MEVP & General Counsel | Sale | −2,420 | $77.00 | $186K | 0direct | Apr 21, 2021 | Apr 23, 2021 | Form 4 ↗ |
| Moriarty Thomas MEVP & General Counsel | Sale | −101.0K | $77.00 | $7.8M | 2,420direct | Apr 21, 2021 | Apr 23, 2021 | Form 4 ↗ |
| Clark James DavidSVP, Cont & Chief Acct Officer | Sale | −5,350 | $76.00 | $407K | 7,244direct | Mar 31, 2021 | Apr 1, 2021 | Form 4 ↗ |
| Moriarty Thomas MEVP & General Counsel | Sale | −62.9K | $76.15 | $4.8M | 0direct | Mar 29, 2021 | Mar 30, 2021 | Form 4 ↗ |
| Roberts Jonathan CEVP & Chief Operating Officer | Sale | −73.4K | $74.49 | $5.5M | 664direct | Mar 26, 2021 | Mar 29, 2021 | Form 4 ↗ |
| MERLO LARRY JDirector | Sale | −270.6K | $74.73 | $20.2M | 524.0Kdirect | Mar 26, 2021 | Mar 29, 2021 | Form 4 ↗ |
| Moriarty Thomas MEVP & General Counsel | Sale | −49.2K | $74.15 | $3.6M | 18.2Kindirect | Mar 19, 2021 | Mar 23, 2021 | Form 4 ↗ |
| Boratto Eva CEVP & CFO | Sale | −18.9K | $74.68 | $1.4M | 71.1Kdirect | Mar 16, 2021 | Mar 17, 2021 | Form 4 ↗ |
| LUDWIG EDWARD JDirector | Purchase | +3,000 | $72.00 | $216K | 14.3Kdirect | Feb 17, 2021 | Feb 17, 2021 | Form 4 ↗ |
| MERLO LARRY JPresident and CEO · Director | Sale | −62.9K | $77.00 | $4.8M | 523.3Kdirect | Jan 19, 2021 | Jan 21, 2021 | Form 4 ↗ |
| Bisaccia LisaEVP and Chief HR Officer | Sale | −25.2K | $77.00 | $1.9M | 46.6Kdirect | Jan 12, 2021 | Jan 13, 2021 | Form 4 ↗ |
| Lotvin AlanEVP and President-CVS Caremark | Sale | −25.8K | $75.00 | $1.9M | 8,369direct | Jan 8, 2021 | Jan 12, 2021 | Form 4 ↗ |
| Brennan Troyen AEVP and Chief Medical Officer | Sale | −58.9K | $75.00 | $4.4M | 46.0Kdirect | Jan 8, 2021 | Jan 12, 2021 | Form 4 ↗ |
| Lotvin AlanEVP and President-CVS Caremark | Sale | −7,138 | $70.00 | $500K | 8,023direct | Nov 13, 2020 | Nov 17, 2020 | Form 4 ↗ |
| Flum Joshua MatthewEVP, ENT STRATEGY & DIGITAL | Sale | −21.5K | $70.00 | $1.5M | 25.0Kdirect | Nov 10, 2020 | Nov 12, 2020 | Form 4 ↗ |
| Mayhew Jonathan E.EVP - Transformation | Sale | −10.6K | $65.00 | $686K | 4,732direct | May 26, 2020 | May 28, 2020 | Form 4 ↗ |
| Clark James DavidSVP, Cont & Chief Acct Officer | Sale | −270 | $65.00 | $18K | 4,547direct | May 26, 2020 | May 28, 2020 | Form 4 ↗ |
| Lotvin AlanEVP and President-CVS Caremark | Purchase | +5,000 | $63.14 | $316K | 15.2Kdirect | May 11, 2020 | May 13, 2020 | Form 4 ↗ |
| Clark James DavidSVP, Cont & Chief Acct Officer | Sale | −6,234 | $65.00 | $405K | 4,817direct | Apr 28, 2020 | Apr 30, 2020 | Form 4 ↗ |
| Clark James DavidSVP, Cont & Chief Acct Officer | Sale | −3,030 | $60.00 | $182K | 9,760direct | Mar 30, 2020 | Apr 1, 2020 | Form 4 ↗ |
| MERLO LARRY JPresident and CEO · Director | Sale | −266.5K | $74.79 | $19.9M | 437.0Kdirect | Jan 15, 2020 | Jan 17, 2020 | Form 4 ↗ |
| Roberts Jonathan CEVP & Chief Operating Officer | Sale | −57.6K | $72.63 | $4.2M | 45.0Kdirect | Jan 8, 2020 | Jan 10, 2020 | Form 4 ↗ |
| Lynch Karen SEVP & Pres, Aetna Bus Unit | Sale | −80.1K | $75.00 | $6.0M | 41.8Kdirect | Nov 18, 2019 | Nov 20, 2019 | Form 4 ↗ |
| Brennan Troyen AEVP and Chief Medical Officer | Sale | −23.6K | $68.00 | $1.6M | 84.3Kdirect | Nov 4, 2019 | Nov 6, 2019 | Form 4 ↗ |
| Flum Joshua MatthewEVP, ENT STRATEGY & DIGITAL | Sale | −17.7K | $63.00 | $1.1M | 18.5Kdirect | Sep 30, 2019 | Oct 1, 2019 | Form 4 ↗ |
| Boratto Eva CEVP & CFO | Sale | −8,130 | $65.00 | $528K | 47.1Kdirect | Sep 12, 2019 | Sep 13, 2019 | Form 4 ↗ |
| BROWN C DAVID IIDirector | Purchase | +10.0K | $53.18 | $532K | 111.3Kdirect | Mar 11, 2019 | Mar 11, 2019 | Form 4 ↗ |
| AGUIRRE FERNANDODirector | Purchase | +1,900 | $53.59 | $102K | 16.2Kdirect | Mar 11, 2019 | Mar 11, 2019 | Form 4 ↗ |
| LUDWIG EDWARD JDirector | Purchase | +2,000 | $52.80 | $106K | 7,378direct | Mar 8, 2019 | Mar 11, 2019 | Form 4 ↗ |
| DORMAN DAVID WDirector | Purchase | +9,600 | $52.71 | $506K | 122.3Kdirect | Mar 8, 2019 | Mar 11, 2019 | Form 4 ↗ |
| AGUIRRE FERNANDODirector | Purchase | +3,410 | $58.29 | $199K | 14.3Kdirect | Mar 1, 2019 | Mar 4, 2019 | Form 4 ↗ |
| LUDWIG EDWARD JDirector | Purchase | +4,000 | $58.27 | $233K | 5,378direct | Mar 1, 2019 | Mar 4, 2019 | Form 4 ↗ |
| Clark James DavidSVP, Cont & Chief Acct Officer | Sale | −1,664 | $58.14 | $97K | 6,893direct | Mar 1, 2019 | Mar 1, 2019 | Form 4 ↗ |
| MERLO LARRY JPresident and CEO · Director | Sale | −166.4K | $64.51 | $10.7M | 330.2Kdirect | Feb 1, 2019 | Feb 4, 2019 | Form 4 ↗ |
| Roberts Jonathan CEVP & Chief Operating Officer | Sale | −77.6K | $64.54 | $5.0M | 33.8Kdirect | Feb 1, 2019 | Feb 4, 2019 | Form 4 ↗ |
| MERLO LARRY JPresident and CEO · Director | Sale | −166.4K | $69.04 | $11.5M | 330.2Kdirect | Jan 8, 2019 | Jan 10, 2019 | Form 4 ↗ |
| Denton David MEVP and CFO | Sale | −25.2K | $80.13 | $2.0M | 403direct | Nov 29, 2018 | Nov 30, 2018 | Form 4 ↗ |
| Brennan Troyen AEVP and Chief Medical Officer | Sale | −14.2K | $82.00 | $1.2M | 70.5Kdirect | Nov 14, 2018 | Nov 16, 2018 | Form 4 ↗ |
| Boratto Eva CEVP, Cont & Chief Acct Officer | Sale | −4,426 | $80.00 | $354K | 41.9Kdirect | Oct 1, 2018 | Oct 3, 2018 | Form 4 ↗ |
| Bisaccia LisaEVP and Chief HR Officer | Sale | −13.8K | $80.00 | $1.1M | 21.1Kdirect | Oct 1, 2018 | Oct 3, 2018 | Form 4 ↗ |
| Bisaccia LisaEVP and Chief HR Officer | Sale | −7,764 | $80.00 | $621K | 21.1Kdirect | Oct 1, 2018 | Oct 3, 2018 | Form 4 ↗ |
| Boratto Eva CEVP, Cont & Chief Acct Officer | Sale | −13.3K | $77.16 | $1.0M | 41.9Kdirect | Sep 17, 2018 | Sep 19, 2018 | Form 4 ↗ |
| Hourican KevinEVP & President, CVS Pharmacy | Sale | −8,564 | $75.00 | $642K | 3,571direct | Aug 27, 2018 | Aug 29, 2018 | Form 4 ↗ |
| DORMAN DAVID WDirector | Purchase | +24.3K | $62.22 | $1.5M | 104.6Kdirect | May 4, 2018 | May 7, 2018 | Form 4 ↗ |
| BROWN C DAVID IIDirector | Purchase | +10.0K | $61.99 | $620K | 101.3Kdirect | May 4, 2018 | May 7, 2018 | Form 4 ↗ |
| Foulkes HelenaEVP & President-CVS Pharmacy | Sale | −20.0K | $71.04 | $1.4M | 45.1Kdirect | Feb 16, 2018 | Feb 21, 2018 | Form 4 ↗ |
| Bisaccia LisaEVP and Chief HR Officer | Sale | −29.4K | $75.00 | $2.2M | 15.6Kdirect | Dec 21, 2017 | Dec 22, 2017 | Form 4 ↗ |
| Moriarty Thomas MEVP & General Counsel | Sale | −20.5K | $81.17 | $1.7M | 22.6Kdirect | Oct 2, 2017 | Oct 3, 2017 | Form 4 ↗ |
| Roberts Jonathan CEVP & Chief Operating Officer | Sale | −85.7K | $83.14 | $7.1M | 33.8Kdirect | Sep 18, 2017 | Sep 19, 2017 | Form 4 ↗ |
| Foulkes HelenaEVP & President-CVS Pharmacy | Sale | −39.3K | $81.88 | $3.2M | 45.0Kdirect | Sep 15, 2017 | Sep 19, 2017 | Form 4 ↗ |
| MERLO LARRY JPresident and CEO · Director | Sale | −241.2K | $83.07 | $20.0M | 299.3Kdirect | Sep 13, 2017 | Sep 15, 2017 | Form 4 ↗ |
| Denton David MEVP and CFO | Sale | −108.2K | $79.62 | $8.6M | 36.1Kdirect | Sep 11, 2017 | Sep 12, 2017 | Form 4 ↗ |
| Denton David MEVP and CFO | Sale | −105.0K | $79.68 | $8.4M | 36.1Kdirect | Sep 11, 2017 | Sep 12, 2017 | Form 4 ↗ |
| Denton David MEVP and CFO | Sale | −23.9K | $79.61 | $1.9M | 141.1Kdirect | Sep 11, 2017 | Sep 12, 2017 | Form 4 ↗ |
| Moriarty Thomas MEVP & General Counsel | Sale | −49.2K | $79.61 | $3.9M | 29.0Kdirect | Sep 11, 2017 | Sep 12, 2017 | Form 4 ↗ |
| Moriarty Thomas MEVP & General Counsel | Sale | −41.1K | $79.61 | $3.3M | 29.0Kdirect | Sep 11, 2017 | Sep 12, 2017 | Form 4 ↗ |
| SWIFT RICHARD JDirector | Sale | −2,500 | $79.62 | $199K | 3,258direct | Aug 16, 2017 | Aug 18, 2017 | Form 4 ↗ |
| Foulkes HelenaEVP, President-CVS Pharmacy | Sale | −20.3K | $80.00 | $1.6M | 45.0Kdirect | Jun 26, 2017 | Jun 28, 2017 | Form 4 ↗ |
| Foulkes HelenaEVP, President-CVS Pharmacy | Sale | −20.3K | $76.98 | $1.6M | 45.0Kdirect | Jun 19, 2017 | Jun 21, 2017 | Form 4 ↗ |
| Denton David MEVP and CFO | Sale | −230.5K | $80.00 | $18.4M | 164.6Kdirect | Jun 12, 2017 | Jun 13, 2017 | Form 4 ↗ |
| Brennan Troyen AEVP and Chief Medical Officer | Sale | −7,212 | $78.73 | $568K | 70.5Kdirect | Mar 21, 2017 | Mar 22, 2017 | Form 4 ↗ |
| Brennan Troyen AEVP and Chief Medical Officer | Sale | −16.6K | $78.73 | $1.3M | 77.7Kdirect | Mar 21, 2017 | Mar 22, 2017 | Form 4 ↗ |
| Boratto Eva CEVP, Cont & Chief Acct Officer | Sale | −6,029 | $79.60 | $480K | 35.6Kdirect | Mar 17, 2017 | Mar 20, 2017 | Form 4 ↗ |
| Sussman AndrewEVP, Clinical Services | Sale | −7,449 | $80.40 | $599K | 8,697direct | Mar 13, 2017 | Mar 14, 2017 | Form 4 ↗ |
| Sussman AndrewEVP, Clinical Services | Sale | −6,655 | $80.40 | $535K | 16.1Kdirect | Mar 13, 2017 | Mar 14, 2017 | Form 4 ↗ |
| Denton David MEVP and CFO | Sale | −95.6K | $80.68 | $7.7M | 154.7Kdirect | Mar 10, 2017 | Mar 13, 2017 | Form 4 ↗ |
| Roberts Jonathan CEVP & President, CVS Caremark | Sale | −61.2K | $80.00 | $4.9M | 28.8Kdirect | Feb 16, 2017 | Feb 17, 2017 | Form 4 ↗ |
| MERLO LARRY JPresident and CEO · Director | Sale | −76.5K | $78.32 | $6.0M | 242.2Kdirect | Feb 1, 2017 | Feb 3, 2017 | Form 4 ↗ |
| GOLD STEPHEN JEVP & CIO | Sale | −9,798 | $105.00 | $1.0M | 21.6Kdirect | May 5, 2016 | May 6, 2016 | Form 4 ↗ |
| Brennan Troyen AEVP and Chief Medical Officer | Sale | −7,517 | $105.00 | $789K | 69.6Kdirect | May 5, 2016 | May 6, 2016 | Form 4 ↗ |
| MERLO LARRY JPresident and CEO · Director | Sale | −38.2K | $105.00 | $4.0M | 242.1Kdirect | May 5, 2016 | May 6, 2016 | Form 4 ↗ |
| Sussman AndrewEVP & Pres, CVS MinuteClinic | Sale | −2,844 | $105.00 | $299K | 11.0Kdirect | Apr 1, 2016 | Apr 5, 2016 | Form 4 ↗ |
| GOLD STEPHEN JEVP & CIO | Sale | −21.9K | $105.00 | $2.3M | 20.1Kdirect | Apr 1, 2016 | Apr 5, 2016 | Form 4 ↗ |
| Brennan Troyen AEVP, Chief Medical Officer | Sale | −6,755 | $100.00 | $676K | 69.6Kdirect | Mar 9, 2016 | Mar 11, 2016 | Form 4 ↗ |
| MERLO LARRY JPresident and CEO · Director | Sale | −38.2K | $100.00 | $3.8M | 223.0Kdirect | Mar 9, 2016 | Mar 11, 2016 | Form 4 ↗ |
| Roberts Jonathan CEVP & President, CVS/caremark | Sale | −23.4K | $92.86 | $2.2M | 28.6Kdirect | Feb 11, 2016 | Feb 11, 2016 | Form 4 ↗ |
| MERLO LARRY JPresident and CEO · Director | Sale | −46.4K | $96.14 | $4.5M | 161.6Kdirect | Feb 1, 2016 | Feb 2, 2016 | Form 4 ↗ |
| MERLO LARRY JPresident and CEO · Director | Sale | −46.4K | $95.00 | $4.4M | 161.6Kdirect | Jan 11, 2016 | Jan 13, 2016 | Form 4 ↗ |
| Finucane Anne A.Director | Sale | −2,000 | $95.87 | $192K | 14.7Kindirect | Jan 4, 2016 | Jan 5, 2016 | Form 4 ↗ |
| Brennan Troyen AEVP, Chief Medical Officer | Sale | −23.6K | $105.00 | $2.5M | 61.8Kdirect | Oct 27, 2015 | Oct 28, 2015 | Form 4 ↗ |
| Boratto Eva CSVP, Cont & Chief Acct Officer | Sale | −22.1K | $110.34 | $2.4M | 24.3Kdirect | Jul 20, 2015 | Jul 21, 2015 | Form 4 ↗ |
| Bisaccia LisaEVP, Chief HR Officer | Sale | −12.1K | $110.00 | $1.3M | 21.0Kdirect | Jul 15, 2015 | Jul 16, 2015 | Form 4 ↗ |
| Bisaccia LisaEVP, Chief HR Officer | Sale | −7,764 | $110.00 | $854K | 21.0Kdirect | Jul 15, 2015 | Jul 16, 2015 | Form 4 ↗ |
| Bisaccia LisaEVP, Chief HR Officer | Sale | −8,392 | $110.00 | $923K | 21.0Kdirect | Jul 15, 2015 | Jul 16, 2015 | Form 4 ↗ |
| Bisaccia LisaEVP, Chief HR Officer | Sale | −6,884 | $110.00 | $757K | 21.0Kdirect | Jul 15, 2015 | Jul 16, 2015 | Form 4 ↗ |
| Bisaccia LisaEVP, Chief HR Officer | Sale | −6,884 | $110.01 | $757K | 21.0Kdirect | Jul 15, 2015 | Jul 16, 2015 | Form 4 ↗ |
| Bisaccia LisaEVP, Chief HR Officer | Sale | −7,926 | $110.00 | $872K | 21.0Kdirect | Jul 15, 2015 | Jul 16, 2015 | Form 4 ↗ |
| BROWN C DAVID IIDirector | Sale | −10.0K | $102.57 | $1.0M | 91.3Kdirect | Jun 1, 2015 | Jun 2, 2015 | Form 4 ↗ |
| BROWN C DAVID IIDirector | Sale | −15.0K | $100.27 | $1.5M | 101.3Kdirect | May 1, 2015 | May 4, 2015 | Form 4 ↗ |
| Sussman AndrewEVP & Pres, CVS/minuteclinic | Sale | −5,082 | $102.39 | $520K | 8,861direct | Apr 10, 2015 | Apr 13, 2015 | Form 4 ↗ |
| Sussman AndrewEVP & Pres, CVS/minuteclinic | Sale | −6,655 | $102.38 | $681K | 13.9Kdirect | Apr 10, 2015 | Apr 13, 2015 | Form 4 ↗ |
| Sussman AndrewEVP & Pres, CVS/minuteclinic | Sale | −5,901 | $102.38 | $604K | 13.9Kdirect | Apr 10, 2015 | Apr 13, 2015 | Form 4 ↗ |
| Brennan Troyen AEVP, Chief Medical Officer | Sale | −16.6K | $102.71 | $1.7M | 61.8Kdirect | Apr 2, 2015 | Apr 3, 2015 | Form 4 ↗ |
| Brennan Troyen AEVP, Chief Medical Officer | Sale | −16.7K | $102.26 | $1.7M | 57.5Kdirect | Apr 1, 2015 | Apr 3, 2015 | Form 4 ↗ |
| Brennan Troyen AEVP, Chief Medical Officer | Sale | −33.3K | $104.94 | $3.5M | 55.1Kdirect | Mar 23, 2015 | Mar 24, 2015 | Form 4 ↗ |
| BROWN C DAVID IIDirector | Sale | −25.0K | $104.30 | $2.6M | 116.3Kdirect | Mar 20, 2015 | Mar 23, 2015 | Form 4 ↗ |
| Roberts Jonathan CEVP & President, CVS/caremark | Sale | −86.5K | $95.31 | $8.2M | 31.5Kdirect | Jan 7, 2015 | Jan 8, 2015 | Form 4 ↗ |
| MERLO LARRY JPresident and CEO · Director | Sale | −144.1K | $94.30 | $13.6M | 76.1Kdirect | Jan 5, 2015 | Jan 6, 2015 | Form 4 ↗ |
| Sussman AndrewSVP & Pres, CVS/minuteclinic | Sale | −4,220 | $95.67 | $404K | 2,817direct | Jan 2, 2015 | Jan 5, 2015 | Form 4 ↗ |
| Brennan Troyen AEVP, Chief Medical Officer | Sale | −50.2K | $95.71 | $4.8M | 41.2Kdirect | Jan 2, 2015 | Jan 5, 2015 | Form 4 ↗ |
| Lofberg Per GHEVP | Sale | −347.3K | $95.28 | $33.1M | 23.4Kdirect | Jan 2, 2015 | Jan 5, 2015 | Form 4 ↗ |
| Foulkes HelenaEVP, President-CVS/pharmacy | Sale | −12.1K | $88.07 | $1.1M | 18.1Kdirect | Nov 7, 2014 | Nov 10, 2014 | Form 4 ↗ |
| Foulkes HelenaEVP, President-CVS/pharmacy | Sale | −14.3K | $88.07 | $1.3M | 18.1Kdirect | Nov 7, 2014 | Nov 10, 2014 | Form 4 ↗ |
| Foulkes HelenaEVP, President-CVS/pharmacy | Sale | −20.0K | $88.06 | $1.8M | 18.1Kdirect | Nov 7, 2014 | Nov 10, 2014 | Form 4 ↗ |
| Bisaccia LisaSVP, Chief HR Officer | Sale | −5,921 | $85.00 | $503K | 17.3Kdirect | Oct 27, 2014 | Oct 28, 2014 | Form 4 ↗ |
| Bisaccia LisaSVP, Chief HR Officer | Sale | −12.1K | $85.00 | $1.0M | 23.2Kdirect | Oct 27, 2014 | Oct 28, 2014 | Form 4 ↗ |
| Bisaccia LisaSVP, Chief HR Officer | Sale | −15.5K | $85.00 | $1.3M | 23.2Kdirect | Oct 27, 2014 | Oct 28, 2014 | Form 4 ↗ |
| Sussman AndrewSVP & President, MinuteClinic | Sale | −9,020 | $79.45 | $717K | 7,037direct | Sep 2, 2014 | Sep 3, 2014 | Form 4 ↗ |
| Joyner J. DavidEVP, Sales & Account Services | Sale | −45.9K | $76.10 | $3.5M | 45.4Kdirect | Aug 6, 2014 | Aug 7, 2014 | Form 4 ↗ |
| Joyner J. DavidEVP, Sales & Account Services | Sale | −77.6K | $76.10 | $5.9M | 45.4Kdirect | Aug 6, 2014 | Aug 7, 2014 | Form 4 ↗ |
| Boratto Eva CSVP, Cont & Chief Acct Officer | Sale | −22.1K | $76.77 | $1.7M | 17.8Kdirect | Jul 21, 2014 | Jul 22, 2014 | Form 4 ↗ |
| Denton David MEVP, CFO | Sale | −75.0K | $75.88 | $5.7M | 86.9Kdirect | Jul 1, 2014 | Jul 3, 2014 | Form 4 ↗ |
| Sussman AndrewSVP & President, MinuteClinic | Sale | −5,901 | $74.02 | $437K | 6,829direct | Apr 2, 2014 | Apr 3, 2014 | Form 4 ↗ |
| Sussman AndrewSVP & President, MinuteClinic | Sale | −13.3K | $74.02 | $985K | 6,829direct | Apr 2, 2014 | Apr 3, 2014 | Form 4 ↗ |
| Boratto Eva CSVP, Cont & Chief Acct Officer | Sale | −4,425 | $74.51 | $330K | 17.7Kdirect | Apr 2, 2014 | Apr 3, 2014 | Form 4 ↗ |
| Boratto Eva CSVP, Cont & Chief Acct Officer | Sale | −6,029 | $74.51 | $449K | 17.7Kdirect | Apr 2, 2014 | Apr 3, 2014 | Form 4 ↗ |
| Boratto Eva CSVP, Cont & Chief Acct Officer | Sale | −6,654 | $74.51 | $496K | 17.7Kdirect | Apr 2, 2014 | Apr 3, 2014 | Form 4 ↗ |
| Brennan Troyen AEVP, Chief Medical Officer | Sale | −3,456 | $75.00 | $259K | 33.5Kdirect | Mar 31, 2014 | Mar 31, 2014 | Form 4 ↗ |
| Brennan Troyen AEVP, Chief Medical Officer | Sale | −15.4K | $74.18 | $1.1M | 36.9Kdirect | Mar 28, 2014 | Mar 31, 2014 | Form 4 ↗ |
| Joyner J. DavidEVP, Sales & Account Services | Sale | −95.1K | $70.47 | $6.7M | 28.5Kdirect | Jan 3, 2014 | Jan 3, 2014 | Form 4 ↗ |
| Joyner J. DavidEVP, Sales & Account Services | Sale | −125.3K | $70.50 | $8.8M | 28.5Kdirect | Jan 3, 2014 | Jan 3, 2014 | Form 4 ↗ |
| Denton David MEVP, CFO | Sale | −14.1K | $70.50 | $995K | 58.0Kdirect | Jan 3, 2014 | Jan 3, 2014 | Form 4 ↗ |
| Lofberg Per GHEVP and President, Caremark | Sale | −53.1K | $70.61 | $3.8M | 46.4Kdirect | Jan 3, 2014 | Jan 3, 2014 | Form 4 ↗ |
| Lofberg Per GHEVP and President, Caremark | Sale | −102.0K | $70.47 | $7.2M | 46.4Kdirect | Jan 3, 2014 | Jan 3, 2014 | Form 4 ↗ |
| Lofberg Per GHEVP and President, Caremark | Sale | −234.1K | $70.47 | $16.5M | 46.4Kdirect | Jan 3, 2014 | Jan 3, 2014 | Form 4 ↗ |
| Lofberg Per GHEVP and President, Caremark | Sale | −401.7K | $70.58 | $28.4M | 46.4Kdirect | Jan 2, 2014 | Jan 3, 2014 | Form 4 ↗ |
| MERLO LARRY JPresident and CEO · Director | Sale | −68.0K | $70.75 | $4.8M | 117.0Kdirect | Jan 2, 2014 | Jan 3, 2014 | Form 4 ↗ |
| MERLO LARRY JPresident and CEO · Director | Sale | −68.0K | $70.74 | $4.8M | 117.0Kdirect | Jan 2, 2014 | Jan 3, 2014 | Form 4 ↗ |
| MERLO LARRY JPresident and CEO · Director | Sale | −46.4K | $70.75 | $3.3M | 117.0Kdirect | Jan 2, 2014 | Jan 3, 2014 | Form 4 ↗ |
| MERLO LARRY JPresident and CEO · Director | Sale | −46.4K | $70.80 | $3.3M | 117.0Kdirect | Jan 2, 2014 | Jan 3, 2014 | Form 4 ↗ |
| Roberts Jonathan CEVP & President, Caremark | Sale | −101.7K | $70.61 | $7.2M | 29.3Kdirect | Jan 2, 2014 | Jan 3, 2014 | Form 4 ↗ |
| Roberts Jonathan CEVP & President, Caremark | Sale | −60.5K | $70.61 | $4.3M | 29.3Kdirect | Jan 2, 2014 | Jan 3, 2014 | Form 4 ↗ |
| Bisaccia LisaSVP, Chief HR Officer | Sale | −12.1K | $68.00 | $820K | 8,476direct | Dec 10, 2013 | Dec 11, 2013 | Form 4 ↗ |
| Boratto Eva CSVP, Cont & Chief Acct Officer | Sale | −6,654 | $66.50 | $442K | 12.7Kdirect | Nov 22, 2013 | Nov 25, 2013 | Form 4 ↗ |
| Bisaccia LisaSVP, Chief HR Officer | Sale | −15.3K | $66.00 | $1.0M | 8,476direct | Nov 21, 2013 | Nov 25, 2013 | Form 4 ↗ |
| Brennan Troyen AEVP, Chief Medical Officer | Sale | −35.4K | $65.61 | $2.3M | 36.0Kdirect | Nov 18, 2013 | Nov 18, 2013 | Form 4 ↗ |
| Foulkes HelenaExecutive Vice President | Sale | −24.1K | $65.00 | $1.6M | 17.9Kdirect | Nov 14, 2013 | Nov 15, 2013 | Form 4 ↗ |
| Boratto Eva CSVP, Cont & Chief Acct Officer | Sale | −6,029 | $63.50 | $383K | 12.7Kdirect | Nov 5, 2013 | Nov 7, 2013 | Form 4 ↗ |
| Boratto Eva CSVP, Cont & Chief Acct Officer | Sale | −11.1K | $60.50 | $669K | 12.7Kdirect | Oct 18, 2013 | Oct 21, 2013 | Form 4 ↗ |
| Boratto Eva CSVP, Cont & Chief Acct Officer | Sale | −11.1K | $59.50 | $658K | 12.7Kdirect | Oct 11, 2013 | Oct 15, 2013 | Form 4 ↗ |
| COSBY MARKEVP & President-CVS/pharmacy | Sale | −26.9K | $57.37 | $1.5M | 46.0Kdirect | Sep 30, 2013 | Oct 1, 2013 | Form 4 ↗ |
| COSBY MARKEVP & President-CVS/pharmacy | Sale | −115.0K | $57.38 | $6.6M | 72.8Kdirect | Sep 30, 2013 | Oct 1, 2013 | Form 4 ↗ |
| Foulkes HelenaExecutive Vice President | Sale | −40.7K | $60.00 | $2.4M | 17.8Kdirect | Sep 13, 2013 | Sep 13, 2013 | Form 4 ↗ |
| Foulkes HelenaExecutive Vice President | Sale | −12.8K | $60.00 | $769K | 17.8Kdirect | Sep 12, 2013 | Sep 13, 2013 | Form 4 ↗ |
| Foulkes HelenaExecutive Vice President | Sale | −47.6K | $58.65 | $2.8M | 17.8Kdirect | Sep 9, 2013 | Sep 11, 2013 | Form 4 ↗ |
| Sussman AndrewSVP & President, MinuteClinic | Sale | −9,020 | $58.36 | $526K | 3,963direct | Sep 4, 2013 | Sep 5, 2013 | Form 4 ↗ |
| Brennan Troyen AEVP, Chief Medical Officer | Sale | −70.8K | $57.34 | $4.1M | 30.1Kdirect | Apr 15, 2013 | Apr 16, 2013 | Form 4 ↗ |
| Brennan Troyen AEVP, Chief Medical Officer | Sale | −34.4K | $57.22 | $2.0M | 30.1Kdirect | Apr 15, 2013 | Apr 16, 2013 | Form 4 ↗ |
| Brennan Troyen AEVP, Chief Medical Officer | Sale | −34.4K | $57.34 | $2.0M | 30.1Kdirect | Apr 15, 2013 | Apr 16, 2013 | Form 4 ↗ |
| Finucane Anne A.Director | Sale | −500 | $57.24 | $29K | 11.3Kindirect | Apr 15, 2013 | Apr 16, 2013 | Form 4 ↗ |
| Brennan Troyen AEVP, Chief Medical Officer | Sale | −6,222 | $54.00 | $336K | 27.6Kdirect | Mar 19, 2013 | Mar 20, 2013 | Form 4 ↗ |
| Brennan Troyen AEVP, Chief Medical Officer | Sale | −28.2K | $54.00 | $1.5M | 27.6Kdirect | Mar 18, 2013 | Mar 20, 2013 | Form 4 ↗ |
| PICCOLO C ADirector | Sale | −50.0K | $48.96 | $2.4M | 181.5Kdirect | Dec 14, 2012 | Dec 17, 2012 | Form 4 ↗ |
| PICCOLO C ADirector | Sale | −48.6K | $49.38 | $2.4M | 231.5Kdirect | Dec 14, 2012 | Dec 17, 2012 | Form 4 ↗ |
| Sussman AndrewSVP & President, MinuteClinic | Sale | −9,020 | $49.00 | $442K | 3,929direct | Oct 4, 2012 | Oct 5, 2012 | Form 4 ↗ |
| Bisaccia LisaSVP, Chief HR Officer | Sale | −12.1K | $48.48 | $585K | 3,147direct | Oct 1, 2012 | Oct 3, 2012 | Form 4 ↗ |
| Bisaccia LisaSVP, Chief HR Officer | Sale | −13.8K | $48.41 | $670K | 15.2Kdirect | Oct 1, 2012 | Oct 3, 2012 | Form 4 ↗ |
| Bisaccia LisaSVP, Chief HR Officer | Sale | −30.6K | $48.40 | $1.5M | 29.0Kdirect | Oct 1, 2012 | Oct 3, 2012 | Form 4 ↗ |
| Moriarty Thomas MEVP & General Counsel | Purchase | +6,164 | $48.67 | $300K | 6,164direct | Oct 1, 2012 | Oct 3, 2012 | Form 4 ↗ |
| Joyner J. DavidEVP, Sales & Account Services | Sale | −33.9K | $48.00 | $1.6M | 21.8Kdirect | Sep 19, 2012 | Sep 21, 2012 | Form 4 ↗ |
| Finucane Anne A.Director | Sale | −1,000 | $46.87 | $47K | 9,684indirect | Sep 17, 2012 | Sep 18, 2012 | Form 4 ↗ |
| Joyner J. DavidEVP, Sales & Account Services | Sale | −20.0K | $47.00 | $940K | 1,786direct | Sep 13, 2012 | Sep 17, 2012 | Form 4 ↗ |
| Denton David MEVP, CFO | Sale | −11.5K | $47.00 | $542K | 32.5Kdirect | Sep 13, 2012 | Sep 14, 2012 | Form 4 ↗ |
| Roberts Jonathan CEVP & President, Caremark | Sale | −32.3K | $45.55 | $1.5M | 25.8Kdirect | Sep 4, 2012 | Sep 5, 2012 | Form 4 ↗ |
| Roberts Jonathan CEVP & President, Caremark | Sale | −32.3K | $45.54 | $1.5M | 58.1Kdirect | Sep 4, 2012 | Sep 5, 2012 | Form 4 ↗ |
| MILLON JEAN PIERREDirector | Sale | −33.7K | $45.73 | $1.5M | 0direct | Aug 21, 2012 | Aug 22, 2012 | Form 4 ↗ |
| Joyner J. DavidEVP, Sales & Account Services | Sale | −10.0K | $47.00 | $470K | 21.8Kdirect | Jul 19, 2012 | Jul 23, 2012 | Form 4 ↗ |
| Joyner J. DavidEVP, Sales & Account Services | Sale | −30.0K | $46.20 | $1.4M | 31.8Kdirect | Jul 19, 2012 | Jul 23, 2012 | Form 4 ↗ |
| GOLD STEPHEN JSVP & CIO | Purchase | +9,516 | $47.29 | $450K | 9,516direct | Jul 9, 2012 | Jul 10, 2012 | Form 4 ↗ |
| Bisaccia LisaSVP, Chief HR Officer | Sale | −11.3K | $48.00 | $544K | 3,147direct | Jul 3, 2012 | Jul 5, 2012 | Form 4 ↗ |
| Bisaccia LisaSVP, Chief HR Officer | Sale | −5,354 | $48.03 | $257K | 14.5Kdirect | Jul 3, 2012 | Jul 5, 2012 | Form 4 ↗ |
| Bisaccia LisaSVP, Chief HR Officer | Sale | −3,938 | $46.89 | $185K | 3,147direct | Jul 2, 2012 | Jul 5, 2012 | Form 4 ↗ |
| MERLO LARRY JPresident and CEO · Director | Sale | −80.7K | $46.96 | $3.8M | 147.4Kdirect | Jul 2, 2012 | Jul 3, 2012 | Form 4 ↗ |
| MERLO LARRY JPresident and CEO · Director | Sale | −80.7K | $46.95 | $3.8M | 147.4Kdirect | Jul 2, 2012 | Jul 3, 2012 | Form 4 ↗ |
| Foulkes HelenaExecutive Vice President | Sale | −64.2K | $45.97 | $3.0M | 8,763direct | Jun 21, 2012 | Jun 22, 2012 | Form 4 ↗ |
| Foulkes HelenaExecutive Vice President | Sale | −23.4K | $45.97 | $1.1M | 73.0Kdirect | Jun 21, 2012 | Jun 22, 2012 | Form 4 ↗ |
| Foulkes HelenaExecutive Vice President | Sale | −5,749 | $46.03 | $265K | 8,763direct | Jun 21, 2012 | Jun 22, 2012 | Form 4 ↗ |
| SGARRO DOUGLAS AEVP and CLO | Sale | −35.0K | $46.17 | $1.6M | 214direct | May 11, 2012 | May 14, 2012 | Form 4 ↗ |
| SGARRO DOUGLAS AEVP and CLO | Sale | −137.9K | $46.19 | $6.4M | 214direct | May 3, 2012 | May 7, 2012 | Form 4 ↗ |
| SGARRO DOUGLAS AEVP and CLO | Sale | −4,608 | $44.65 | $206K | 214direct | Apr 4, 2012 | Apr 4, 2012 | Form 4 ↗ |
| SGARRO DOUGLAS AEVP and CLO | Sale | −64.2K | $44.96 | $2.9M | 4,822direct | Apr 2, 2012 | Apr 4, 2012 | Form 4 ↗ |
| SGARRO DOUGLAS AEVP and CLO | Sale | −23.4K | $44.96 | $1.1M | 69.1Kdirect | Apr 2, 2012 | Apr 4, 2012 | Form 4 ↗ |
| SGARRO DOUGLAS AEVP and CLO | Sale | −44.6K | $44.96 | $2.0M | 92.5Kdirect | Apr 2, 2012 | Apr 4, 2012 | Form 4 ↗ |
| Brennan Troyen AEVP, Chief Medical Officer | Sale | −48.2K | $44.96 | $2.2M | 22.5Kdirect | Apr 2, 2012 | Apr 4, 2012 | Form 4 ↗ |
| MCGUIGAN STUART MSVP and CIO | Sale | −17.8K | $45.22 | $807K | 11.0Kdirect | Mar 16, 2012 | Mar 20, 2012 | Form 4 ↗ |
| BANKS EDWIN MDirector | Sale | −33.7K | $45.11 | $1.5M | 23.2Kdirect | Mar 15, 2012 | Mar 16, 2012 | Form 4 ↗ |
| BANKS EDWIN MDirector | Sale | −33.7K | $45.11 | $1.5M | 56.9Kdirect | Mar 15, 2012 | Mar 16, 2012 | Form 4 ↗ |
| SGARRO DOUGLAS AEVP and CLO | Sale | −154.9K | $44.97 | $7.0M | 214direct | Mar 15, 2012 | Mar 15, 2012 | Form 4 ↗ |
| BANKS EDWIN MDirector | Sale | −46.8K | $45.17 | $2.1M | 23.2Kdirect | Mar 14, 2012 | Mar 16, 2012 | Form 4 ↗ |
| BANKS EDWIN MDirector | Sale | −46.9K | $45.13 | $2.1M | 70.0Kdirect | Mar 14, 2012 | Mar 16, 2012 | Form 4 ↗ |
| SGARRO DOUGLAS AEVP and CLO | Sale | −43.3K | $45.06 | $2.0M | 155.2Kdirect | Mar 14, 2012 | Mar 15, 2012 | Form 4 ↗ |
| SGARRO DOUGLAS AEVP and CLO | Sale | −136.1K | $45.06 | $6.1M | 198.4Kdirect | Mar 14, 2012 | Mar 15, 2012 | Form 4 ↗ |
| SGARRO DOUGLAS AEVP and CLO | Sale | −44.6K | $45.06 | $2.0M | 334.5Kdirect | Mar 14, 2012 | Mar 15, 2012 | Form 4 ↗ |
| SGARRO DOUGLAS AEVP and CLO | Sale | −26.0K | $45.06 | $1.2M | 379.2Kdirect | Mar 14, 2012 | Mar 15, 2012 | Form 4 ↗ |
| SGARRO DOUGLAS AEVP and CLO | Sale | −102.5K | $44.93 | $4.6M | 198.4Kdirect | Mar 13, 2012 | Mar 15, 2012 | Form 4 ↗ |
| SGARRO DOUGLAS AEVP and CLO | Sale | −147.5K | $44.93 | $6.6M | 300.9Kdirect | Mar 13, 2012 | Mar 15, 2012 | Form 4 ↗ |
| Foulkes HelenaExecutive Vice President | Sale | −20.3K | $44.86 | $910K | 11.2Kdirect | Mar 1, 2012 | Mar 2, 2012 | Form 4 ↗ |
| Foulkes HelenaExecutive Vice President | Sale | −5,588 | $44.89 | $251K | 11.2Kdirect | Mar 1, 2012 | Mar 2, 2012 | Form 4 ↗ |
| Bisaccia LisaSVP, Chief HR Officer | Sale | −10.7K | $43.67 | $468K | 3,590direct | Feb 22, 2012 | Feb 23, 2012 | Form 4 ↗ |
| Bisaccia LisaSVP, Chief HR Officer | Sale | −12.0K | $43.67 | $523K | 3,590direct | Feb 22, 2012 | Feb 23, 2012 | Form 4 ↗ |
| Brennan Troyen AEVP, Chief Medical Officer | Sale | −96.4K | $44.03 | $4.2M | 16.5Kdirect | Feb 21, 2012 | Feb 22, 2012 | Form 4 ↗ |
| MCGUIGAN STUART MSVP and CIO | Sale | −30.6K | $43.15 | $1.3M | 11.0Kdirect | Feb 13, 2012 | Feb 15, 2012 | Form 4 ↗ |
| Lofberg Per GHEVP and President, Caremark | Purchase | +46.4K | $42.99 | $2.0M | 69.8Kdirect | Feb 13, 2012 | Feb 15, 2012 | Form 4 ↗ |
| MILLON JEAN PIERREDirector | Sale | −33.7K | $38.90 | $1.3M | 0direct | Nov 16, 2011 | Nov 18, 2011 | Form 4 ↗ |
| MCGUIGAN STUART MSVP and CIO | Sale | −42.8K | $38.15 | $1.6M | 10.1Kdirect | Nov 8, 2011 | Nov 10, 2011 | Form 4 ↗ |
| Denton David MEVP, CFO | Sale | −5,334 | $37.00 | $197K | 33.6Kdirect | Sep 14, 2011 | Sep 16, 2011 | Form 4 ↗ |
| WILLIAMS KRISTEN GIBNEYDirector | Sale | −7,107 | $35.46 | $252K | 64.7Kindirect | Sep 2, 2011 | Sep 7, 2011 | Form 4 ↗ |
| Roberts Jonathan CEVP & COO, Caremark | Sale | −48.0K | $36.01 | $1.7M | 18.6Kdirect | Sep 1, 2011 | Sep 6, 2011 | Form 4 ↗ |
| Foulkes HelenaExecutive Vice President | Sale | −10.3K | $37.49 | $386K | 12.8Kdirect | Jun 16, 2011 | Jun 20, 2011 | Form 4 ↗ |
| Foulkes HelenaExecutive Vice President | Sale | −16.7K | $37.49 | $625K | 23.0Kdirect | Jun 16, 2011 | Jun 20, 2011 | Form 4 ↗ |
| MURRAY TERRENCEDirector | Sale Amended | −75 | $37.91 | $3K | 80.5Kdirect | May 23, 2011 | Oct 7, 2011 | Form 4 ↗ |
| MERLO LARRY JPresident and CEO · Director | Sale | −80.0K | $38.01 | $3.0M | 147.3Kdirect | May 12, 2011 | May 13, 2011 | Form 4 ↗ |
| MURRAY TERRENCEDirector | Sale | −2,800 | $36.23 | $101K | 76.9Kdirect | Apr 29, 2011 | May 25, 2011 | Form 4 ↗ |
| MERLO LARRY JPresident and CEO · Director | Sale | −144.8K | $36.00 | $5.2M | 147.3Kdirect | Apr 6, 2011 | Apr 8, 2011 | Form 4 ↗ |
| Bisaccia LisaSVP, Chief HR Officer | Sale | −3,207 | $33.04 | $106K | 0direct | Mar 1, 2011 | Mar 3, 2011 | Form 4 ↗ |
| MURRAY TERRENCEDirector | Purchase Amended | +35 | $32.57 | $1K | 80.5Kdirect | Feb 22, 2011 | Oct 7, 2011 | Form 4 ↗ |
| MURRAY TERRENCEDirector | Purchase Amended | +35 | $32.86 | $1K | 80.5Kdirect | Feb 15, 2011 | Oct 7, 2011 | Form 4 ↗ |
| Roberts Jonathan CExecutive Vice President | Sale | −24.0K | $33.40 | $802K | 18.5Kdirect | Feb 9, 2011 | Feb 11, 2011 | Form 4 ↗ |
| MURRAY TERRENCEDirector | Purchase | +2,800 | $33.28 | $93K | 79.7Kdirect | Feb 8, 2011 | May 25, 2011 | Form 4 ↗ |
| MERLO LARRY JPresident and COO | Sale | −80.0K | $34.87 | $2.8M | 143.1Kdirect | Jan 3, 2011 | Jan 5, 2011 | Form 4 ↗ |
| RYAN THOMAS MChairman of the Board and CEO · Director | Sale | −400.0K | $33.06 | $13.2M | 764.7Kdirect | Dec 7, 2010 | Dec 9, 2010 | Form 4 ↗ |
| RYAN THOMAS MChairman of the Board and CEO · Director | Sale | −1.0M | $33.06 | $33.5M | 764.7Kdirect | Dec 7, 2010 | Dec 9, 2010 | Form 4 ↗ |
| MERLO LARRY JPresident and COO | Sale | −100.0K | $32.35 | $3.2M | 143.1Kdirect | Dec 6, 2010 | Dec 7, 2010 | Form 4 ↗ |
| MERLO LARRY JPresident and COO | Sale | −44.8K | $32.35 | $1.4M | 143.1Kdirect | Dec 6, 2010 | Dec 7, 2010 | Form 4 ↗ |
| MERLO LARRY JPresident and COO | Sale | −96.7K | $32.50 | $3.1M | 143.1Kdirect | Dec 6, 2010 | Dec 7, 2010 | Form 4 ↗ |
| MERLO LARRY JPresident and COO | Sale | −3,300 | $32.50 | $107K | 143.1Kdirect | Dec 3, 2010 | Dec 7, 2010 | Form 4 ↗ |
| Bisaccia LisaSVP, Chief HR Officer | Sale | −12.4K | $31.04 | $384K | 1,004direct | Nov 9, 2010 | Nov 10, 2010 | Form 4 ↗ |
| RYAN THOMAS MCEO · Director | Sale | −500.0K | $31.02 | $15.5M | 756.6Kdirect | Nov 8, 2010 | Nov 10, 2010 | Form 4 ↗ |
| RYAN THOMAS MCEO · Director | Sale | −400.0K | $30.93 | $12.4M | 756.6Kdirect | Nov 8, 2010 | Nov 10, 2010 | Form 4 ↗ |
| Lofberg Per GHPresident, Caremark Pharm Serv | Purchase | +4,000 | $29.08 | $116K | 162.0Kindirect | Aug 17, 2010 | Aug 18, 2010 | Form 4 ↗ |
| Lofberg Per GHPresident, Caremark Pharm Serv | Purchase | +11.0K | $29.86 | $328K | 158.0Kindirect | Aug 9, 2010 | Aug 11, 2010 | Form 4 ↗ |
| MURRAY TERRENCEDirector | Sale Amended | −45 | $31.75 | $1K | 80.5Kdirect | Jun 25, 2010 | Oct 7, 2011 | Form 4 ↗ |
Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Jun 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →